Separately, HC Wainwright set a $12.00 target price on Myomo and gave the company a buy rating in a research note on Thursday, March 8th.
Myomo (MYO) opened at $4.22 on Friday. Myomo has a twelve month low of $2.07 and a twelve month high of $23.20. The company has a market capitalization of $25.96 and a PE ratio of -0.79.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://sportsperspectives.com/2018/03/13/myomo-myo-research-coverage-started-at-roth-capital.html.
Myomo, Inc is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke.
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.